 Connection
Adane Wogu to Male
This is a "connection" page, showing publications Adane Wogu has written about Male.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.116 |
|
|
|
-
Wogu AF, Dixon JM, Xiao M, Lategan HJ, Oosthuizen G, Schauer SG, Steyn E, Bhaumik S, Verster J, Wylie C, de Vries S, Mayet M, Hodsdon L, Wagner L, Snyders LO, Doubell K, Lourens D, Stassen W, Rees C, Young J, Moore EE, Mould-Millman NK. Tranexamic acid is associated with post-injury mortality in a resource-limited trauma system: Findings from the epidemiology and outcomes of prolonged trauma care cohort study. Transfusion. 2025 May; 65 Suppl 1:S276-S287.
Score: 0.032
-
Wogu AF, Loffredo CA, Bebu I, Luta G. Mediation analysis of gestational age, congenital heart defects, and infant birth-weight. BMC Res Notes. 2014 Dec 17; 7:926.
Score: 0.016
-
Goryachok M, Liu J, Benjamin T, Fischer BG, Lai AR, Levy KL, Wogu AF, Evans AT, Baduashvili A. A Randomized Trial of Interval Likelihood Ratios for Clinical Decision-Making. NEJM Evid. 2026 Jul; 5(7):EVIDoa2500249.
Score: 0.009
-
Dixon JM, Wogu AF, Rodriguez MD, Barnhart D, Patel R, Lategan HJ, Oosthuizen G, Verster J, de Vries S, Wylie C, Erasmus E, Schauer SG, Mould-Millman NK. Mortality Benefit of Tranexamic Acid for Hemorrhage With Concurrent Traumatic Brain Injury: Outcomes From a Prospective Cohort Study in a High-Trauma, Prolonged Care Setting. World J Surg. 2026 Jan; 50(1):233-243.
Score: 0.008
-
Bhaumik S, Hendrikse C, Verster J, Erasmus E, Lategan H, de Vries S, Mukonkole S, Jamison M, Wogu A, Xiao M, Dixon J, Finn J, Finck L, Wagner L, Stassen W, Wylie C, Hodsdon L, Doubell K, Mayet M, Snyders L, Ginde A, Mould-Millman NK. Association between community assault and adverse renal outcomes among patients with crush injury in South Africa: a retrospective cohort study. Emerg Med J. 2025 Nov 21; 42(12):810-816.
Score: 0.008
-
Fish LE, Roberts SC, Bennett TD, Carlson NE, Hamer MK, Kwan BM, Russell S, Wogu AF, Wynia MK, Ginde AA. Experiences of recently diagnosed urban COVID-19 outpatients: A survey on patient worries, provider-patient interactions, and neutralizing monoclonal antibody treatment. PLoS One. 2025; 20(6):e0325991.
Score: 0.008
-
Mould-Millman NK, Wogu AF, Fosdick BK, Dixon JM, Beaty BL, Bhaumik S, Lategan HJ, Stassen W, Schauer SG, Steyn E, Verster J, Wylie C, de Vries S, Jamison M, Kohlbrenner M, Mayet M, Hodsdon L, Wagner L, Snyders LO, Doubell K, Lourens D, Bebarta VS. Association of freeze-dried plasma with 24-h mortality among trauma patients at risk for hemorrhage. Transfusion. 2024 05; 64 Suppl 2:S155-S166.
Score: 0.008
-
Douin DJ, Wogu AF, Beaty LE, Carlson NE, Bennett TD, Aggarwal NR, Mayer DA, Ong TC, Russell S, Steele J, Peers JL, Molina KC, Wynia MK, Ginde AA. Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients. BMC Infect Dis. 2022 Nov 07; 22(1):818.
Score: 0.007
-
Ataga KI, Elsherif L, Wichlan D, Wogu AF, Matsui N, Pawlinski R, Cai J, Key NS. A pilot study of the effect of rivaroxaban in sickle cell anemia. Transfusion. 2021 06; 61(6):1694-1698.
Score: 0.006
-
Ataga KI, Wichlan D, Elsherif L, Derebail VK, Wogu AF, Maitra P, Cai J, Caughey MC, Pollock DM, Pollock JS, Archer DR, Hinderliter AL. A pilot study of the effect of atorvastatin on endothelial function and albuminuria in sickle cell disease. Am J Hematol. 2019 11; 94(11):E299-E301.
Score: 0.005
-
Whelihan MF, Lim MY, Mooberry MJ, Piegore MG, Ilich A, Wogu A, Cai J, Monroe DM, Ataga KI, Mann KG, Key NS. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease. J Thromb Haemost. 2016 10; 14(10):1941-1952.
Score: 0.004
-
Shayne M, Culakova E, Poniewierski MS, Dale DC, Crawford J, Wogu AF, Lyman GH. Risk factors for in-hospital mortality and prolonged length of stay in older patients with solid tumor malignancies. J Geriatr Oncol. 2013 Oct; 4(4):310-8.
Score: 0.004
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|